The Preferred Vascular Group acquisition by Surgery Partners marks a strategic expansion into the rapidly growing dialysis access market. The transaction strengthens Surgery Partners’ position within specialised outpatient vascular care.

Moreover, the deal gives the surgical services operator entry into a sector valued at approximately $6 billion annually. The dialysis access segment performs more than two million procedures each year, creating a large addressable opportunity.

Ziegler acted as the exclusive financial advisor to Preferred Vascular Group (PVG) throughout the transaction process.

Strategic Entry Into the Dialysis Access Market

The Preferred Vascular Group acquisition by Surgery Partners provides immediate access to a specialised clinical segment focused on dialysis access procedures.

PVG operates eight ambulatory surgery centres (ASCs) located in Georgia and Ohio. These facilities deliver outpatient services designed for patients requiring vascular access creation and maintenance.

Furthermore, the organisation employs 16 physicians and more than 160 healthcare professionals. Its clinical teams support nephrologists and dialysis clinics across regional healthcare networks.

Because dialysis access procedures require ongoing monitoring and intervention, demand for these services remains consistently high. Therefore, specialised outpatient facilities can deliver cost-efficient treatment while maintaining strong clinical outcomes.

Strengthening Surgery Partners’ Ambulatory Surgery Network

Surgery Partners continues to pursue growth through targeted acquisitions and facility development. Consequently, the addition of PVG enhances its vascular service capabilities.

PVG’s leadership team will remain in place to manage the operating platform. This continuity ensures operational stability during integration.

Additionally, Surgery Partners intends to leverage PVG’s expertise across its national network of surgical centres. This approach may accelerate the expansion of dialysis access services in new markets.

By combining operational scale with specialised clinical expertise, the partnership aims to improve patient access to high-quality outpatient vascular care.

Ziegler’s Advisory Role in the Transaction

Ziegler served as exclusive financial advisor to PVG during the sale process. The investment bank guided the company through a competitive transaction environment.

According to PVG CEO Dustin Greene, the advisory partnership proved instrumental throughout the negotiation process. As a result, the company secured an agreement with a publicly listed surgical platform capable of supporting future expansion.

Andrew Colbert, Senior Managing Director in Ziegler’s Healthcare Investment Banking division, noted that PVG holds a differentiated position within the vascular care sector. Specifically, the company focuses on dialysis access procedures that address a critical need within the dialysis treatment ecosystem.

Market Implications for Outpatient Vascular Care

The acquisition highlights growing consolidation within the ambulatory surgery centre sector.

Dialysis access procedures require specialised expertise and frequent patient care interactions. Therefore, dedicated outpatient facilities can offer both cost efficiency and clinical consistency.

Industry observers will likely monitor how PVG expands within Surgery Partners’ national platform. In particular, investors may assess how the integration influences case mix, margins and future acquisition activity.

Overall, the transaction reflects a broader healthcare trend toward specialised outpatient care delivery models.